Abstract
Background: This study aimed to examine the prevalence of hepatitis B virus (HBV) in people with HIV (PWH) undergoing contemporary antiretroviral therapy and people without HIV and to understand the risk factors in people with HIV/HBV coinfection. This retrospective cross-sectional study included 5238 participants with HIV or at risk for HIV acquisition across 13 US sites in the MACS/WIHS Combined Cohort Study (Multicenter AIDS Cohort Study / Women Interagency HIV Study) between January 2018 and December 2024. Methods: The primary outcome was the prevalence of HBV infection and HIV/HBV coinfection. We defined a positive HBsAg (surface antigen) as chronic HBV infection, a negative HBsAg and positive anti-HBV core antibody as recovered infection, and a negative HBsAg and negative anti-HBV core antibody as never infection. The prevalence of chronic and recovered HBV infection was described in different risk groups. Results: In this cohort, the overall prevalence of chronic HBV was 2.4%, and HIV/HBV coinfection was 3.0% among PWH. Current and prior HBV infection was more common in men, and the prevalence of prior HBV increased with age. As compared with the other 2 groups, PWH with chronic HBV infection had lower CD4+ T-cell counts (567 vs 651 and 689 cells/µL), CD4+ T-cell nadirs (210 vs 245 and 258 cells/µL), and HIV viral suppression rate (71.7% vs 82.3% and 83.7%). Among PWH who never had HBV infection, 40.6% lacked seroprotection against HBV. Conclusions: HBV is still prevalent in PWH. HBV coinfection was associated with lower CD4+ T-cell counts and viral suppression rate in PWH. The low seroprotection rate in those without HBV underscores the need for improved screening and immunization.
Funding Information
  • MWCCS
  • Atlanta
  • Clinical Research Site (U01-HL146241)
  • Baltimore CRS (U01-HL146201)
  • Bronx CRS (U01-HL146204)
  • Brooklyn CRS (U01-HL146202)
  • Data Analysis and Coordination Center (U01-HL146193)
  • Chicago–Cook County CRS (U01-HL146245)
  • Chicago–Northwestern CRS (U01-HL146240)
  • Los Angeles CRS (U01-HL146333)
  • Metropolitan Washington CRS (U01-HL146205)
  • Miami CRS (U01-HL146203)
  • Northern California CRS (U01-HL146242)
  • Pittsburgh CRS (U01-HL146208)
  • University of Alabama at Birmingham–Multiple Sclerosis Center CRS (U01-HL146192)
  • University of North Carolina CRS (U01-HL146194)
  • National Heart, Lung, and Blood Institute
  • Eunice Kennedy Shriver
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • National Institute on Aging
  • National Institute of Dental and Craniofacial Research
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Neurological Disorders and Stroke
  • National Institute of Mental Health
  • National Institute on Drug Abuse
  • National Institute of Nursing Research
  • National Cancer Institute
  • National Institute on Alcohol Abuse and Alcoholism
  • National Institute on Deafness and Other Communication Disorders
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute on Minority Health and Health Disparities
  • Office of AIDS Research
  • National Institutes of Health (UL1-TR000004)
  • UCSF CTSA (UL1-TR003098)
  • JHU ICTR (UL1-TR001881)
  • Clinical and Translational Science Institute, University of California, Los Angeles (P30-AI-050409)
  • Atlanta CFAR (P30-AI-073961)
  • Miami CFAR (P30-AI-050410)
  • Center for AIDS Research, University of North Carolina at Chapel Hill (P30-AI-027767)
  • Center for AIDS Research, Heersink School of Medicine, University of Alabama at Birmingham (P30-MH-116867)
  • Miami CHARM (UL1-TR001409)
  • DC CTSA (KL2-TR001432)
  • DC CTSA (TL1-TR001431)
  • DC CTSA

This publication has 13 references indexed in Scilit: